The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

Arboviruses are spreading beyond tropical and subtropical regions due to climate change, population growth, and increased ...

Vaccine maker Moderna announced today that the US Food and Drug Administration (FDA) has granted full approval of its ...